Well, if you watch the show, you know that the calendar may say 2025, but it is a busy month in the 2028 presidential shadow primary. You're never not worrying about the presidential race. California Governor Gavin Newsome wrapped up a rural outreach tour a long way from home in South Carolina earlier this week.Kentucky Governor Andy Basher and Congressman Roana of California will be making trips to the Palmetto State, which I think hosts an early primary there for the presidential race. Other early primary ...

The AI Talent Race Heats Up https://t.co/jpfRzBo3rs https://t.co/jPdqWF1m0T ...

Thanks so much, Melissa Reed. Thanks so much for joining me here in Sun Valley. I want to start off with a topic that I'm hearing a lot of conversation about, which is the AI talent war.We've heard how Meta and Open AAI are in this AI talent war. They're competing with Microsoft, which you're on the board of, along with Apple and Amazon and Google for AI talent and also just competing in this AI race in general. Which of these companies do you think is best positioned to win the AI race. Well, I think the g ...

Group 1 - The natural gas market is showing potential for a bullish breakout if it surpasses the recent high of $3,346, which would also place it above the 20-Day and 50-Day moving averages [1] - A bullish reversal for natural gas will only be confirmed with a rise above the recent lower swing high at $3,366 [1] - Gold is consolidating near the highs of a long-term uptrend, with a significant resistance level at $3,451, which needs to be broken for a reliable bullish signal [2] Group 2 - The pullback low of the pennant for gold at $2,121 found support around the 38.2% Fibonacci retracement level, indicating sustained buying strength [3] - A drop below the swing low of $3,243 would indicate weakness in gold and could lead to a retest of support around the 38.2% retracement level, potentially falling to the 50% retracement level at $3,041 [4]

The AI Talent Race Heats Uphttps://t.co/moh7PNG4nW https://t.co/ATX209HVKY ...

NEW: 🇺🇸 Kevin O’Leary says the U.S. should look to Bitcoin miners as a model to stay competitive in the AI arms race.He argues their strategy of building in low-cost energy regions offers a blueprint for AI infrastructure, and warns America is falling behind. https://t.co/QnIBkyFSsC ...

Core Insights - Lottery.com Inc. is actively involved in the NTT INDYCAR SERIES and INDY NXT, showcasing its brand through sponsorship of drivers and teams during high-profile racing events [2][8]. Performance Summary - Callum Ilott, driving for PREMA Racing, achieved his best result of the season by finishing P13 after starting from P24, demonstrating a strong recovery and effective race strategy [3][4]. - Louis Foster, a rookie with Rahal Letterman Lanigan Racing, qualified P6 and finished P14, maintaining his lead in the Rookie of the Year standings despite challenges during the race [5][6]. - Sebastian Murray, racing for Andretti Global, faced an early exit due to a collision on Lap 4, which ended his race prematurely after a promising start [7][8]. Company Statements - Matthew McGahan, CEO of Lottery.com and Sports.com, expressed pride in the drivers' performances, highlighting their achievements and the visibility of the brands during the Fourth of July weekend [8][9]. - Marc Bircham, Main Board Director, praised the drivers for their professionalism and competitive spirit, indicating confidence in their future performances as the season progresses [9]. Company Overview - Lottery.com Inc. operates a unified ecosystem that integrates gaming, entertainment, and sports, with brands including Sports.com, Tinbu, and WinTogether [10].

DNase I Oncology Platform - The company is focused on advancing its proprietary DNase I technology platform to address multiple high-value cancer indications[2, 5] - DNase I targets Neutrophil Extracellular Traps (NETs) to improve immunotherapies and chemotherapies[2, 5] - DNase I digests both double and single-stranded DNA, as well as DNA:RNA hybrids, exposing cancer cells to the immune system and reducing therapy resistance[6] - Systemic administration of DNase I improves the efficacy of PD-1 blockade, resulting in the lowest tumor volume growth compared to either DNase I or anti-PD-1 alone[19] Pipeline and Clinical Development - The company's lead program, XBIO-015, combines systemic DNase I with chemotherapy for pancreatic carcinoma[7] - A Phase 1 study is planned, featuring dose escalation and expansion in subjects with locally advanced or metastatic solid tumors, with pancreatic cancer and other solid tumor indications[2, 40] - The company believes that an ORR greater than 50% or PFS greater than 9 months would be a meaningful improvement to the current standard of care for pancreatic cancer[45] Market Opportunity - The company is initially targeting pancreatic carcinoma, a multi-billion-dollar indication with significant unmet need, with a projected market of $48 billion by 2025[2, 39] - Approximately 62,000 people are diagnosed with pancreatic cancer annually, and approximately 50,000 die from it annually[39] - There were approximately 19 million new solid tumor cases in the U S in 2022, leading to approximately 6 million solid tumor-related deaths[46] Collaboration and Intellectual Property - The company is collaborating with VolitionRX to develop proprietary adoptive cell therapies potentially targeting multiple solid cancer types[2, 58] - VolitionRX is expected to fund the research program, with both parties sharing proceeds from commercialization or licensing of any resulting products[60] - The company has an IP portfolio covering the co-administration of Systemic DNase I with ICIs, radiation, and chemo, as well as DNase I for pancreatic cancer and DNase I-secreting CAR T cells[62, 64]

Corporate Presentation June 2025 JENNIFER Living with SCA3 JENNIFER Living with SCA3 Participant in the Troriluzole Clinical Study © 2025 Biohaven, Ltd. All rights reserved. Forward-Looking Statement This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about Biohaven Ltd. (the "Company") and our planned and ongoing trials for our troriluzole, taldefgrobep alfa, BHV-7000, BHV-2100, BHV-8000, BHV-1300, BHV-1400, ...

President Trump was on hand for the opening of so-called Alligator Alcatraz yesterday. That's the new immigration detention center in the Florida Everglades. The president toured the facility alongside Homeland Security Secretary Christy Gnome and Republican Florida Governor Ron DeSantis.They said they hoped the first detainees would arrive there within the next 24 hours with the president adding he'd like to see more states develop these kinds of facilities. You don't always have land so beautiful and so s ...